Newly self-administered two-step tool for screening cognitive function in an ageing Chinese population: an exploratory cross-sectional study

Background Early screening of cognitive function is critical to dementia treatment and care. However, traditional tests require face-to-face administration and are often limited by implementation costs and biases. Aims This study aimed to assess whether the Thoven Cognitive Self-Assessment (TCSA), a novel, innovative two-step touchscreen-based cognition assessment tool, could identify early cognitive impairment due to dementia in older adults. Methods The TCSA was administered to 61 healthy controls (HCs), 46 participants with mild cognitive impairment (MCI) and 44 participants diagnosed with dementia recruited from Shanghai. Two outcome measures were generated from the TCSA test: the TCSAprimary task score and the TCSAsecondary task score. Results The total average scores in the control group for the TCSAprimary task and TCSAsecondary task were significantly higher than those in the MCI and dementia groups (TCSAprimary task: HCs vs MCI group vs dementia group, 8.58±1.76 vs 5.40±2.67 vs 2.74±2.11, F=75.40, p<0.001; TCSAsecondary task: HCs vs MCI group vs dementia group, 23.02±3.31 vs 17.95±4.93 vs 11.93±5.50, F=76.46, p<0.001). Moreover, receiver operating characteristic analysis showed that a score below 7.5 for the TCSAprimary task and a score below 22.5 for the TCSAsecondary task were indicators of MCI. Conclusions The TCSA appears to be efficacious for the detection of cognitive impairment in older adults. It demonstrates the potential for large-scale cognition screening in community service settings.

[1]  Jian-Yun Nie,et al.  Efficacy of comprehensive cognitive health management for Shanghai community older adults with mild cognitive impairment , 2022, General Psychiatry.

[2]  G. Wang,et al.  The China Alzheimer Report 2022 , 2022, General Psychiatry.

[3]  Ying Chen,et al.  Characteristics of Dysregulated Proinflammatory Cytokines and Cognitive Dysfunction in Late-Life Depression and Amnestic Mild Cognitive Impairment , 2022, Frontiers in Immunology.

[4]  Bing Zhang,et al.  A comparison of the Mini-Mental State Examination (MMSE) with the Montreal Cognitive Assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population: a cross-sectional study , 2021, BMC Psychiatry.

[5]  J. Wesson Ashford,et al.  Validity of the MemTrax Memory Test Compared to the Montreal Cognitive Assessment in the Detection of Mild Cognitive Impairment and Dementia due to Alzheimer's Disease in a Chinese Cohort. , 2021, Journal of Alzheimer's disease : JAD.

[6]  Kyunghun Kang,et al.  Clinical application of the experimental ADL test for patients with cognitive impairment: pilot study , 2021, Scientific reports.

[7]  H. Takechi,et al.  Usefulness of CogEvo, a computerized cognitive assessment and training tool, for distinguishing patients with mild Alzheimer's disease and mild cognitive impairment from cognitively normal older people , 2020, Geriatrics & gerontology international.

[8]  J. Kaye,et al.  Validation of SATURN, a free, electronic, self‐administered cognitive screening test , 2020, Alzheimer's & dementia.

[9]  J. Ashford,et al.  A Computerized Continuous-Recognition Task for Measurement of Episodic Memory , 2019, Journal of Alzheimer's disease : JAD.

[10]  N. A. Ahmad,et al.  Validity of screening tools for dementia and mild cognitive impairment among the elderly in primary health care: a systematic review. , 2019, Public health.

[11]  A. Salardini,et al.  A Comprehensive Update on Treatment of Dementia , 2019, Seminars in Neurology.

[12]  S. Engelborghs,et al.  Brief cognitive screening instruments for early detection of Alzheimer’s disease: a systematic review , 2019, Alzheimer's Research & Therapy.

[13]  Jie Dai,et al.  Comparison of the value of Mini-Cog and MMSE screening in the rapid identification of Chinese outpatients with mild cognitive impairment , 2018, Medicine.

[14]  Rumona Dickson,et al.  A systematic review of the diagnostic accuracy of automated tests for cognitive impairment , 2018, International journal of geriatric psychiatry.

[15]  Yo-Ping Huang,et al.  Validity of a Novel Touch Screen Tablet-Based Assessment for Mild Cognitive Impairment and Probable AD in Older Adults , 2019, Assessment.

[16]  Quincy M. Samus,et al.  Dementia prevention, intervention, and care , 2017, The Lancet.

[17]  C. Jack,et al.  Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers , 2017, The Lancet Neurology.

[18]  Milton Severo,et al.  Development of a self-administered web-based test for longitudinal cognitive assessment , 2016, Scientific Reports.

[19]  M. Tsolaki,et al.  Computerized Cognitive Testing for Older Adults , 2015, American journal of Alzheimer's disease and other dementias.

[20]  Kristine Yaffe,et al.  Potential for primary prevention of Alzheimer's disease: an analysis of population-based data , 2014, The Lancet Neurology.

[21]  D. William Molloy,et al.  Which part of the Quick mild cognitive impairment screen (Qmci) discriminates between normal cognition, mild cognitive impairment and dementia? , 2013, Age and ageing.

[22]  D. Battle,et al.  Diagnostic and Statistical Manual of Mental Disorders (DSM). , 2013, CoDAS.

[23]  Samrah Ahmed,et al.  A comparison of screening tools for the assessment of Mild Cognitive Impairment: Preliminary findings , 2012, Neurocase.

[24]  A. Mitchell,et al.  A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. , 2009, Journal of psychiatric research.

[25]  Sid E O'Bryant,et al.  Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study. , 2008, Archives of neurology.

[26]  Deborah Blacker,et al.  Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. , 2007, Archives of general psychiatry.

[27]  E. Tangalos,et al.  Neuropathologic features of amnestic mild cognitive impairment. , 2006, Archives of neurology.

[28]  D. Levinson,et al.  Automated neuropsychological assessment metrics (ANAM) measures of cognitive effects of Alzheimer's disease. , 2005, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[29]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[30]  H. Brodaty,et al.  Characteristics of the GPCOG, a screening tool for cognitive impairment , 2004, International journal of geriatric psychiatry.

[31]  Peijun Chen,et al.  The Mini‐Cog as a Screen for Dementia: Validation in a Population‐Based Sample , 2003, Journal of the American Geriatrics Society.

[32]  J. Ashford,et al.  Designing a Brief Alzheimer Screen (BAS). , 2003, Journal of Alzheimer's disease : JAD.

[33]  R. Hall,et al.  Mental Status: Examination , 2015 .

[34]  L. Cronbach Coefficient alpha and the internal structure of tests , 1951 .